Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Serum metabolites associated with brain amyloid beta deposition, cognition and dementia progression
Kwangsik Nho, Alexandra Kueider‐Paisley, Matthias Arnold, et al.
Brain Communications (2021) Vol. 3, Iss. 3
Open Access | Times Cited: 28

Showing 1-25 of 28 citing articles:

Effects of a ketogenic and low‐fat diet on the human metabolome, microbiome, and foodome in adults at risk for Alzheimer's disease
Amanda Hazel Dilmore, Cameron Martino, Bryan J. Neth, et al.
Alzheimer s & Dementia (2023) Vol. 19, Iss. 11, pp. 4805-4816
Open Access | Times Cited: 47
The Alzheimer's Disease Neuroimaging Initiative in the era of Alzheimer's disease treatment: A review of ADNI studies from 2021 to 2022
Dallas P. Veitch, Michael W. Weiner, Melanie J. Miller, et al.
Alzheimer s & Dementia (2023) Vol. 20, Iss. 1, pp. 652-694
Open Access | Times Cited: 35
Consuming a modified Mediterranean ketogenic diet reverses the peripheral lipid signature of Alzheimer’s disease in humans
Bryan J. Neth, Kevin Huynh, Corey Giles, et al.
Communications Medicine (2025) Vol. 5, Iss. 1
Open Access | Times Cited: 1
Predictive metabolic networks reveal sex‐ and APOE genotype‐specific metabolic signatures and drivers for precision medicine in Alzheimer's disease
Rui Chang, Eugenia Trushina, Kuixi Zhu, et al.
Alzheimer s & Dementia (2022) Vol. 19, Iss. 2, pp. 518-531
Open Access | Times Cited: 26
Genome-wide association study of brain biochemical phenotypes reveals distinct genetic architecture of Alzheimer’s disease related proteins
Stephanie R. Oatman, Joseph S. Reddy, Zachary Quicksall, et al.
Molecular Neurodegeneration (2023) Vol. 18, Iss. 1
Open Access | Times Cited: 15
Hallmarks of aging and Alzheimer’s Disease pathogenesis: paving the route for new therapeutic targets
Federico Bellelli, Davide Angioni, Beatrice Arosio, et al.
Ageing Research Reviews (2025) Vol. 106, pp. 102699-102699
Closed Access
IL-17 A Exacerbated Neuroinflammatory and Neurodegenerative Biomarkers in Intranasal Amyloid-Beta Model of Alzheimer’s Disease
Avtar Singh Gautam, Shivam Kumar Pandey, Sneha Balki, et al.
Journal of Neuroimmune Pharmacology (2025) Vol. 20, Iss. 1
Closed Access
Circular-SWAT for deep learning based diagnostic classification of Alzheimer's disease: application to metabolome data
Taeho Jo, Jun Pyo Kim, Paula J. Bice, et al.
EBioMedicine (2023) Vol. 97, pp. 104820-104820
Open Access | Times Cited: 8
Serum Bile Acids Improve Prediction of Alzheimer's Progression in a Sex‐Dependent Manner
Tianlu Chen, Lu Wang, Guoxiang Xie, et al.
Advanced Science (2023) Vol. 11, Iss. 9
Open Access | Times Cited: 8
Investigating associations between blood metabolites, later life brain imaging measures, and genetic risk for Alzheimer’s disease
Rebecca Green, Jodie Lord, Marzia Antonella Scelsi, et al.
Alzheimer s Research & Therapy (2023) Vol. 15, Iss. 1
Open Access | Times Cited: 7
Tryptophan Metabolism and Neurodegeneration: Longitudinal Associations of Kynurenine Pathway Metabolites with Cognitive Performance and Plasma Alzheimer’s Disease and Related Dementias Biomarkers in the Duke Physical Performance Across the LifeSpan Study
Daniel Parker, William E. Kraus, Heather E. Whitson, et al.
Journal of Alzheimer s Disease (2022) Vol. 91, Iss. 3, pp. 1141-1150
Open Access | Times Cited: 12
Longitudinal analysis of UK Biobank participants suggests age and APOE-dependent alterations of energy metabolism in development of dementia
Jun Liu, Najaf Amin, William Sproviero, et al.
medRxiv (Cold Spring Harbor Laboratory) (2022)
Open Access | Times Cited: 11
Potential biomarkers of Alzheimer’s disease and cerebral small vessel disease
Chun Zou, Xiaohua Huang, Yilong Zhang, et al.
Frontiers in Molecular Neuroscience (2022) Vol. 15
Open Access | Times Cited: 11
Advances in peripheral blood biomarkers of patients with Alzheimer’s disease: Moving closer to personalized therapies
Gabriella Ferretti, Sara Serafini, Antonella Angiolillo, et al.
Biomedicine & Pharmacotherapy (2023) Vol. 165, pp. 115094-115094
Open Access | Times Cited: 6
Plasma Metabolite Markers of Parkinson’s Disease and Atypical Parkinsonism
Meerakhan Pathan, Junfang Wu, Hans‐Åke Lakso, et al.
Metabolites (2021) Vol. 11, Iss. 12, pp. 860-860
Open Access | Times Cited: 15
Age and APOE affect L-carnitine system metabolites in the brain in the APOE-TR model
Claire Huguenard, Adam Cseresznye, Teresa Darcey, et al.
Frontiers in Aging Neuroscience (2023) Vol. 14
Open Access | Times Cited: 5
Association of Circulating Caprylic Acid with Risk of Mild Cognitive Impairment and Alzheimer’s Disease in the Alzheimer’s Disease Neuroimaging Initiative (ADNI) Cohort
Lei Fan, Xiaogdong Zhu, Amy R. Borenstein, et al.
The Journal of Prevention of Alzheimer s Disease (2023)
Open Access | Times Cited: 4
Investigating metabolic dysregulation in serum of triple transgenic Alzheimer’s disease male mice: implications for pathogenesis and potential biomarkers
Hongbin Zhuang, Xueshan Cao, Xiaoxiao Tang, et al.
Amino Acids (2024) Vol. 56, Iss. 1
Open Access | Times Cited: 1
Metabolic profiles associated with exposure to ambient particulate air pollution: findings from the Betula cohort
Wasif Raza, Anders Öhman, Katja M. Kanninen, et al.
Frontiers in Public Health (2024) Vol. 12
Open Access | Times Cited: 1
Intestinal endogenous metabolites affect neuroinflammation in 5×FAD mice by mediating “gut-brain” axis and the intervention with Chinese Medicine
Xinru Gu, Miao-Xuan Fan, Yanyan Zhou, et al.
Alzheimer s Research & Therapy (2024) Vol. 16, Iss. 1
Open Access | Times Cited: 1
Therapeutic potential of a modified Mediterranean ketogenic diet in reversing the peripheral lipid signature of Alzheimer’s disease
Bryan J. Neth, Kevin Huynh, Corey Giles, et al.
medRxiv (Cold Spring Harbor Laboratory) (2023)
Open Access | Times Cited: 3
Associations of the Lipidome with Ageing, Cognitive Decline and Exercise Behaviours
Maria Kadyrov, Luke Whiley, Belinda M. Brown, et al.
Metabolites (2022) Vol. 12, Iss. 9, pp. 822-822
Open Access | Times Cited: 5
Dulaglutide ameliorates chronic stress-induced cognitive impairment via regulating gut microbiota and serum metabolites in mice
Shipan Zhang, Man Jin, Boya Huang, et al.
Research Square (Research Square) (2024)
Open Access
Metabolites and MRI-Derived Markers of AD/ADRD Risk in a Puerto Rican Cohort
Scott Paul Gordon, Jong‐Soo Lee, Tammy Scott, et al.
Research Square (Research Square) (2024)
Open Access
The role of GZMA as a target of cysteine and biomarker in Alzheimer’s disease, pelvic organ prolapse, and tumor progression
Yan Li, Zhuo Wang, Min Gyu Kong, et al.
Frontiers in Pharmacology (2024) Vol. 15
Open Access
Page 1 - Next Page

Scroll to top